Clinique Edith Cavell

Brussels 1180

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread — Stopped early